Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2003 Jul;40(7):487–493. doi: 10.1136/jmg.40.7.487

Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain

S Kudo 1, Y Nomura 1, M Segawa 1, N Fujita 1, M Nakao 1, C Schanen 1, M Tamura 1
PMCID: PMC1735522  PMID: 12843318

Abstract

Rett syndrome is a neurodevelopmental disorder with severe mental retardation caused by mutations in the MECP2 gene. Mutations in the MECP2 gene are also associated with other genetic disorders, including X linked mental retardation in males. Missense mutations identified so far are present primarily in the methyl CpG binding domain (MBD) of MECP2. Here, the functional significance of 28 MBD missense mutations identified in patients were analysed by transient expression of the mutant proteins in cultured cells. The effects of mutations were evaluated by analysis of the affinity of MeCP2 to pericentromeric heterochromatin in mouse L929 cells and on transcriptional repressive activity of MeCP2 in Drosophila SL2 cells. These analyses showed that approximately one-third (9/28) of MBD missense mutations showed strong impairment of MeCP2 function. The mutation of the R111 residue, which directly interacts with the methyl group of methyl cytosine, completely abolished MeCP2 function and mutations affecting ß-sheets and a hairpin loop have substantial functional consequences. In contrast, mutations that showed marginal or mild impairment of the function fell in unstructured regions with no DNA interaction. Since each of these mutations is known to be pathogenic, the mutations may indicate residues that are important for specific functions of MeCP2 in neurones.

Full Text

The Full Text of this article is available as a PDF (239.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad Kami, Henikoff Steven. Epigenetic consequences of nucleosome dynamics. Cell. 2002 Nov 1;111(3):281–284. doi: 10.1016/s0092-8674(02)01081-4. [DOI] [PubMed] [Google Scholar]
  2. Amir R. E., Van den Veyver I. B., Wan M., Tran C. Q., Francke U., Zoghbi H. Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999 Oct;23(2):185–188. doi: 10.1038/13810. [DOI] [PubMed] [Google Scholar]
  3. Amir R. E., Zoghbi H. Y. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet. 2000 Summer;97(2):147–152. doi: 10.1002/1096-8628(200022)97:2<147::aid-ajmg6>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  4. Armstrong J., Pineda M., Aibar E., Geán E., Monrós E. Classic Rett syndrome in a boy as a result of somatic mosaicism for a MECP2 mutation. Ann Neurol. 2001 Nov;50(5):692–692. doi: 10.1002/ana.1272. [DOI] [PubMed] [Google Scholar]
  5. Ballestar E., Yusufzai T. M., Wolffe A. P. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry. 2000 Jun 20;39(24):7100–7106. doi: 10.1021/bi0001271. [DOI] [PubMed] [Google Scholar]
  6. Bird A. P., Wolffe A. P. Methylation-induced repression--belts, braces, and chromatin. Cell. 1999 Nov 24;99(5):451–454. doi: 10.1016/s0092-8674(00)81532-9. [DOI] [PubMed] [Google Scholar]
  7. Buyse I. M., Fang P., Hoon K. T., Amir R. E., Zoghbi H. Y., Roa B. B. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet. 2000 Oct 30;67(6):1428–1436. doi: 10.1086/316913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chae Jong Hee, Hwang Yong Seung, Kim Ki Joong. Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome. J Child Neurol. 2002 Jan;17(1):33–36. doi: 10.1177/088307380201700108. [DOI] [PubMed] [Google Scholar]
  9. Cheadle J. P., Gill H., Fleming N., Maynard J., Kerr A., Leonard H., Krawczak M., Cooper D. N., Lynch S., Thomas N. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet. 2000 Apr 12;9(7):1119–1129. doi: 10.1093/hmg/9.7.1119. [DOI] [PubMed] [Google Scholar]
  10. Chen R. Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet. 2001 Mar;27(3):327–331. doi: 10.1038/85906. [DOI] [PubMed] [Google Scholar]
  11. Courey A. J., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 1988 Dec 2;55(5):887–898. doi: 10.1016/0092-8674(88)90144-4. [DOI] [PubMed] [Google Scholar]
  12. Couvert P., Bienvenu T., Aquaviva C., Poirier K., Moraine C., Gendrot C., Verloes A., Andrès C., Le Fevre A. C., Souville I. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001 Apr 15;10(9):941–946. doi: 10.1093/hmg/10.9.941. [DOI] [PubMed] [Google Scholar]
  13. De Bona C., Zappella M., Hayek G., Meloni I., Vitelli F., Bruttini M., Cusano R., Loffredo P., Longo I., Renieri A. Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet. 2000 May;8(5):325–330. doi: 10.1038/sj.ejhg.5200473. [DOI] [PubMed] [Google Scholar]
  14. Free A., Wakefield R. I., Smith B. O., Dryden D. T., Barlow P. N., Bird A. P. DNA recognition by the methyl-CpG binding domain of MeCP2. J Biol Chem. 2000 Oct 16;276(5):3353–3360. doi: 10.1074/jbc.M007224200. [DOI] [PubMed] [Google Scholar]
  15. Guy J., Hendrich B., Holmes M., Martin J. E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet. 2001 Mar;27(3):322–326. doi: 10.1038/85899. [DOI] [PubMed] [Google Scholar]
  16. Hagberg B., Aicardi J., Dias K., Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol. 1983 Oct;14(4):471–479. doi: 10.1002/ana.410140412. [DOI] [PubMed] [Google Scholar]
  17. Hammer Sara, Dorrani Naghmeh, Dragich Joanna, Kudo Shinichi, Schanen Carolyn. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002;8(2):94–98. doi: 10.1002/mrdd.10023. [DOI] [PubMed] [Google Scholar]
  18. Hampson K., Woods C. G., Latif F., Webb T. Mutations in the MECP2 gene in a cohort of girls with Rett syndrome. J Med Genet. 2000 Aug;37(8):610–612. doi: 10.1136/jmg.37.8.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol. 1998 Nov;18(11):6538–6547. doi: 10.1128/mcb.18.11.6538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hoffbuhr K., Devaney J. M., LaFleur B., Sirianni N., Scacheri C., Giron J., Schuette J., Innis J., Marino M., Philippart M. MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology. 2001 Jun 12;56(11):1486–1495. doi: 10.1212/wnl.56.11.1486. [DOI] [PubMed] [Google Scholar]
  21. Huppke P., Laccone F., Krämer N., Engel W., Hanefeld F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet. 2000 May 22;9(9):1369–1375. doi: 10.1093/hmg/9.9.1369. [DOI] [PubMed] [Google Scholar]
  22. Inui K., Akagi M., Ono J., Tsukamoto H., Shimono K., Mano T., Imai K., Yamada M., Muramatsu T., Sakai N. Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome. Brain Dev. 2001 Jul;23(4):212–215. doi: 10.1016/s0387-7604(01)00197-8. [DOI] [PubMed] [Google Scholar]
  23. Jones P. L., Veenstra G. J., Wade P. A., Vermaak D., Kass S. U., Landsberger N., Strouboulis J., Wolffe A. P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998 Jun;19(2):187–191. doi: 10.1038/561. [DOI] [PubMed] [Google Scholar]
  24. Kudo S., Fukuda M. Tissue-specific transcriptional regulation of human leukosialin (CD43) gene is achieved by DNA methylation. J Biol Chem. 1995 Jun 2;270(22):13298–13302. doi: 10.1074/jbc.270.22.13298. [DOI] [PubMed] [Google Scholar]
  25. Kudo S. Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated. Mol Cell Biol. 1998 Sep;18(9):5492–5499. doi: 10.1128/mcb.18.9.5492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kudo S., Nomura Y., Segawa M., Fujita N., Nakao M., Dragich J., Schanen C., Tamura M. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev. 2001 Dec;23 (Suppl 1):S165–S173. doi: 10.1016/s0387-7604(01)00345-x. [DOI] [PubMed] [Google Scholar]
  27. Kudo S., Nomura Y., Segawa M., Fujita N., Nakao M., Hammer S., Schanen C., Terai I., Tamura M. Functional characterisation of MeCP2 mutations found in male patients with X linked mental retardation. J Med Genet. 2002 Feb;39(2):132–136. doi: 10.1136/jmg.39.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Laccone F., Huppke P., Hanefeld F., Meins M. Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions. Hum Mutat. 2001 Mar;17(3):183–190. doi: 10.1002/humu.3. [DOI] [PubMed] [Google Scholar]
  29. Lewis J. D., Meehan R. R., Henzel W. J., Maurer-Fogy I., Jeppesen P., Klein F., Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992 Jun 12;69(6):905–914. doi: 10.1016/0092-8674(92)90610-o. [DOI] [PubMed] [Google Scholar]
  30. Lyko F. DNA methylation learns to fly. Trends Genet. 2001 Apr;17(4):169–172. doi: 10.1016/s0168-9525(01)02234-x. [DOI] [PubMed] [Google Scholar]
  31. Monrós E., Armstrong J., Aibar E., Poo P., Canós I., Pineda M. Rett syndrome in Spain: mutation analysis and clinical correlations. Brain Dev. 2001 Dec;23 (Suppl 1):S251–S253. doi: 10.1016/s0387-7604(01)00374-6. [DOI] [PubMed] [Google Scholar]
  32. Nan X., Ng H. H., Johnson C. A., Laherty C. D., Turner B. M., Eisenman R. N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998 May 28;393(6683):386–389. doi: 10.1038/30764. [DOI] [PubMed] [Google Scholar]
  33. Nan X., Tate P., Li E., Bird A. DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol. 1996 Jan;16(1):414–421. doi: 10.1128/mcb.16.1.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nielsen J. B., Henriksen K. F., Hansen C., Silahtaroglu A., Schwartz M., Tommerup N. MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet. 2001 Mar;9(3):178–184. doi: 10.1038/sj.ejhg.5200600. [DOI] [PubMed] [Google Scholar]
  35. Obata K., Matsuishi T., Yamashita Y., Fukuda T., Kuwajima K., Horiuchi I., Nagamitsu S., Iwanaga R., Kimura A., Omori I. Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome. J Med Genet. 2000 Aug;37(8):608–610. doi: 10.1136/jmg.37.8.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ohki I., Shimotake N., Fujita N., Jee J., Ikegami T., Nakao M., Shirakawa M. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell. 2001 May 18;105(4):487–497. doi: 10.1016/s0092-8674(01)00324-5. [DOI] [PubMed] [Google Scholar]
  37. Ohki I., Shimotake N., Fujita N., Nakao M., Shirakawa M. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1. EMBO J. 1999 Dec 1;18(23):6653–6661. doi: 10.1093/emboj/18.23.6653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Orrico A., Lam C., Galli L., Dotti M. T., Hayek G., Tong S. F., Poon P. M., Zappella M., Federico A., Sorrentino V. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 2000 Sep 22;481(3):285–288. doi: 10.1016/s0014-5793(00)01994-3. [DOI] [PubMed] [Google Scholar]
  39. Shahbazian M. D., Zoghbi H. Y. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr Opin Neurol. 2001 Apr;14(2):171–176. doi: 10.1097/00019052-200104000-00006. [DOI] [PubMed] [Google Scholar]
  40. Shahbazian Mona, Young Juan, Yuva-Paylor Lisa, Spencer Corinne, Antalffy Barbara, Noebels Jeffrey, Armstrong Dawna, Paylor Richard, Zoghbi Huda. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron. 2002 Jul 18;35(2):243–254. doi: 10.1016/s0896-6273(02)00768-7. [DOI] [PubMed] [Google Scholar]
  41. Uchino J., Suzuki M., Hoshino K., Nomura Y., Segawa M. Development of language in Rett syndrome. Brain Dev. 2001 Dec;23 (Suppl 1):S233–S235. doi: 10.1016/s0387-7604(01)00367-9. [DOI] [PubMed] [Google Scholar]
  42. Vacca M., Filippini F., Budillon A., Rossi V., Mercadante G., Manzati E., Gualandi F., Bigoni S., Trabanelli C., Pini G. Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. J Mol Med (Berl) 2001;78(11):648–655. doi: 10.1007/s001090000155. [DOI] [PubMed] [Google Scholar]
  43. Villard L., Kpebe A., Cardoso C., Chelly P. J., Tardieu P. M., Fontes M. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology. 2000 Oct 24;55(8):1188–1193. doi: 10.1212/wnl.55.8.1188. [DOI] [PubMed] [Google Scholar]
  44. Wade P. A., Wolffe A. P. ReCoGnizing methylated DNA. Nat Struct Biol. 2001 Jul;8(7):575–577. doi: 10.1038/89593. [DOI] [PubMed] [Google Scholar]
  45. Wakefield R. I., Smith B. O., Nan X., Free A., Soteriou A., Uhrin D., Bird A. P., Barlow P. N. The solution structure of the domain from MeCP2 that binds to methylated DNA. J Mol Biol. 1999 Sep 3;291(5):1055–1065. doi: 10.1006/jmbi.1999.3023. [DOI] [PubMed] [Google Scholar]
  46. Xiang F., Buervenich S., Nicolao P., Bailey M. E., Zhang Z., Anvret M. Mutation screening in Rett syndrome patients. J Med Genet. 2000 Apr;37(4):250–255. doi: 10.1136/jmg.37.4.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yamashita Y., Kondo I., Fukuda T., Morishima R., Kusaga A., Iwanaga R., Matsuishi T. Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech. Brain Dev. 2001 Dec;23 (Suppl 1):S157–S160. doi: 10.1016/s0387-7604(01)00378-3. [DOI] [PubMed] [Google Scholar]
  48. Zappella M., Meloni I., Longo I., Hayek G., Renieri A. Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet. 2001 Nov 15;104(1):14–22. doi: 10.1002/ajmg.10005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES